Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1898-1908

  Huhtaniemi, Ilpo T ^a   Pye, Stephen R ^b,n   Holliday, Kate L ^b   Thomson, Wendy ^b   O'Neill, Terence W ^b,n   Platt, Hazel ^b   Payne, Debbie ^b   John, Sally L ^b   Jiang, Min ^c   Bartfai, György ^d,n   Boonen, Steven ^e,n   Casanueva, Felipe F ^f,n   Finn, Joseph D ^b,n   Forti, Gianni ^g,n   Giwercman, Aleksander ^h   Han, Thang S ⁱ   Kula, Krzysztof ^j,n   Lean, Michael E J ^k   Pendleton, Neil ^b   Punab, Margus ^l,n   Silman, Alan J ^b,n   Vanderschueren, Dirk ^e,n   Labrie, Fernand ^m   Wu, Frederick C W ^b,n   Petrone, Luisa ⁿ   Corona, Giovanni ⁿ   Borghs, Herman ⁿ   Slowikowska Hilczer, Jolanta ⁿ   Walczak Jedrzejowska, Renata ⁿ   Steer, Philip ⁿ   Tajar, Abdelouahid ⁿ   Lee, David ⁿ   Lage, Mary ⁿ   Földesi, Imre ⁿ   Fejes, Imre ⁿ   Korrovitz, Paul ⁿ   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF SZEGED   (Hungary)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g UNIVERSITY OF FLORENCE   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ ROYAL FREE HOSPITAL   (United Kingdom)

^j MEDICAL UNIVERSITY OF LODZ   (Poland)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

^l TARTU UNIVERSITY CLINICS   (Estonia)

^m UNIVERSITÉ LAVAL   (Canada)

ⁿ Laval University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE; CYTOCHROME P450 17; CYTOCHROME P450 17A1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEMOGLOBIN; LIPID; LUTEINIZING HORMONE BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE 2; UNCLASSIFIED DRUG; DNA; SEX HORMONE;

ADULT; AGED; AGING; ANALYTICAL PARAMETERS; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CIRCULATION; COGNITION; COHORT ANALYSIS; COMMUNITY; CROSS-SECTIONAL STUDY; ENDOCRINE FUNCTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOPHYSIS TESTIS SYSTEM; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; SEXUAL DYSFUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CLINICAL TRIAL; EUROPE; GENE FREQUENCY; GENETIC DATABASE; GENETICS; HYPOPHYSIS; MASS SPECTROMETRY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; TESTIS;

ADULT; AGED; AGING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, GENETIC; DNA; EUROPE; GENE FREQUENCY; GENOTYPE; GONADAL STEROID HORMONES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PITUITARY GLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TESTIS;

EID: 77951634472     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2071     Document Type: Article

References (44)

1. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876
2. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB 2007 The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92: 549-555
3. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D 2008 Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737-2745
4. Ukkola O,Gagnon J, Rankinen T, Thompson PA, Hong Y, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C 2001 Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 145:1-9
5. Jiang M, Huhtaniemi I 2004 Polymorphisms and male ageing. In: Chanson P, Epelbaum J, Lemberts S, Christen UY, eds. Endocrine aspects of successful aging. Berlin, Heidelberg, New York: Springer-Verlag; 63-87
6. Jiang M, Huhtaniemi I 2004 Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol 39: 1603-1611
7. Lee DM, O'Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, Wu FC 2009 The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 32:11-24
8. Limer KL, Pye SR, Thomson W, Boonen S, Borghs H, Vanderschueren D, Huhtaniemi IT, Adams JE, Ward KA, Platt H, Payne D, John SL, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A,Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, O'Neill TW 2009 Genetic variation in sexhormonegenes influences heel ultrasound parameters in middle aged and elderly men: results from the European Male Ageing Study (EMAS). J Bone Miner Res 24:314-323
9. Lamminen T, Huhtaniemi I 2001 A common genetic variant of luteinizing hormone; relation to normal and aberrant pituitarygonadal function. Eur J Pharmacol 414:1-7 (Pubitemid 32174869)
10. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265
11. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J 2006 Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182-188
12. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J 2007 Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 103: 178-188
13. Van Pottelbergh I, Goemaere S, Kaufman JM 2003 Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88:3075-3081
14. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
15. Siri WE 1993 Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition 9:480-491; discussion 480, 492
16. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
17. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME 1993 Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578-582 (Pubitemid 23118305)
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
19. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
20. Bosch JL, Hop WC, Kirkels WJ, Schröder FH 1995 The International Prostate Symptom Score in a community-based sample ofmen between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75:622-630
21. O'Connor DB, Corona G, Forti G, Tajar A, Lee DM, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Huhtaniemi IT, Kula K, O'Neill TW, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC 2008 Assessment of sexual health in aging men in Europe: development and validation of the Europe an Male Ageing Study sexual function questionnaire. J Sex Med 5:1374-1385
22. Hogeveen KN, Talikka M, Hammond GL 2001 Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA) n repeat element within an Alu sequence. J Biol Chem 276: 36383-36390
23. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O'Neill TW, Platt H, Payne D, John SL, Jiang M, Boonen S, Borghs H, Vanderschueren D, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC 2009 Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94:277-284
24. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
25. Meikle AW, Stringham JD, Bishop DT, West DW 1988 Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab 67:104-109
26. Ring HZ, Lessov CN, Reed T, Marcus R, Holloway L, Swan GE, Carmelli D 2005 Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin Endocrinol Metab 90: 3653-3658
27. Rajender S, Singh L, Thangaraj K 2007 Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 9:147-179 (Pubitemid 46416577)
28. Eriksson AL, Lorentzon M, Mellström D, Vandenput L, Swanson C, Andersson N, Hammond GL, Jakobsson J, Rane A, Orwoll ES, Ljunggren O, Johnell O, Labrie F, Windahl SH, Ohlsson C 2006 SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab 91:5029-5037
29. Zmuda JM, Cauley JA, Kuller LH, Ferrell RE 2001 A common promotor variant in the cytochrome P450c17α (CYP17) gene is associated with bioavailability testosterone levels and bone size in men. J Bone Miner Res 16:911-917
30. Eriksson AL, Lorentzon M, Vandenput L, Labrie F, Lindersson M, Syvänen AC, Orwoll ES, Cummings SR, Zmuda JM, Ljunggren O, Karlsson MK, Mellström D, Ohlsson C 2009 Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94:1033-1041
31. Jakobsson J, Palonek E, Lorentzon M, Ohlsson C, Rane A, Ekström L 2007 A novel polymorphism in the 17β-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in Caucasian men. Pharmacogenomics J 7:282-289
32. Swanson C, Mellström D, Lorentzon M, Vandenput L, Jakobsson J, Rane A, Karlsson M, Ljunggren O, Smith U, Eriksson AL, Bélanger A, Labrie F, Ohlsson C 2007 The uridine diphosphate glucurono-syltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab 92:4878-4882
33. Cousin P, Déchaud H, Grenot C, Lejeune H, Pugeat M 1998 Human variant sex hormone-binding globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit. J Clin Endocrinol Metab 83:235-240
34. Turk A, Kopp P, Colangelo LA, Urbanek M, Wood K, Liu K, Skinner HG, Gapstur SM 2008 Associations of serum sex hormone binding globulin (SHBG) levels with SHBG gene polymorphisms in the CARDIA Male Hormone Study. Am J Epidemiol 167:412-418
35. Vanbillemont G, Bogaert V, De Bacquer D, Lapauw B, Goemaere S, Toye K, Van Steen K, Taes Y, Kaufman JM 2009 Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men. Clin Endocrinol (Oxf) 70:303-310
36. Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF 2008 Identification of commonvariants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:3490-3498
37. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S 2009 Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361:1152-1163
38. Raven G, de Jong FH, Kaufman JM, de Ronde W 2006 In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 91:3324-3328
39. van den Beld A, Huhtaniemi IT, Pettersson KS, Pols HA, Grobbee DE, de Jong FH, Lamberts SW 1999 Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 84:1334-1339
40. Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB 2007 Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 121:451-457
41. Medeiros R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lopees C 2003 Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 141:91-96
42. Ntais C, Polycarpou A, Ioannidis JP 2003 SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12:618-624 (Pubitemid 36899841)
43. Allen NE, Forrest MS, Key TJ 2001 The association between polymorphisms in the CYP17 and 5α-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 10:185-189
44. Schatzl G, Madersbacher S, Gsur A, Preyer M, Haidinger G, Haitel A, Vutuc C, Micksche M, Marberger M 2002 Association of polymorphisms within androgen receptor, 5α-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. The Prostate 52:130-138